The Application Value of Spectral CT in the Accurate Staging of Gastric Cancer

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorYunnan Cancer Hospital

About this trial

Spectral CT was used to prospectively collect medical images and clinical data related to gastric cancer, evaluate the effect of image quality in the diagnosis of gastric cancer, and evaluate the application value in the accurate staging of gastric cancer, so as to provide a more accurate clinical basis for diagnosis, promote the development of individualized treatment, and ultimately improve the prognosis of patients.

Eligibility criteria

Qualifiers

(a)Patients with pathologically confirmed gastric cancer;

(b) aged ≥ 18 years old;

(c) have not received chemoradiotherapy or surgery.

Disqualifiers

(a)Combined with other primary tumors;

(b) The image quality does not meet the diagnostic criteria;

(c)Those who cannot tolerate CT examination.

Trial design

Treatments tested in this trial

  • To explore the value of spectral CT in the diagnosis and treatment of gastric cancer

Treatment groups

150 Participants
are divided into 1 treatment group

Sponsors and collaborators